StonvexLoading…
StonvexStonvexStonvexCore line items from PSA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.22B | $4.82B | $3.61B | $2.38B |
Operating Income | $474.28M | $1.79B | $1.29B | $776.87M |
Net Income | $526.27M | $1.78B | $1.28B | $766.21M |
EPS (Diluted) | $2.71 | $9.01 | $6.42 | $3.79 |
Total Assets | $19.85B | $20.21B | $20.11B | $20.54B |
Total Liabilities | $10.53B | $10.87B | $10.71B | $11.07B |
Cash & Equivalents | $134.61M | $318.10M | $296.46M | $1.10B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 175.93M | 175.90M | 175.92M | 175.93M |